Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Trans resveratrol loaded DSPE PEG 2000 coated liposomes: An evidence for prolonged systemic circulation and passive brain targeting
Department of Pharmaceutics, Indian Institute of Technology, Banaras Hindu University, Varanas.
Department of Pharmaceutics, Indian Institute of Technology, Banaras Hindu University, Varanas.
Luleå University of Technology, Department of Health Sciences, Medical Science.ORCID iD: 0000-0003-2645-5719
Department of Pharmaceutics, Indian Institute of Technology, Banaras Hindu University, Varanas.
Show others and affiliations
2016 (English)In: Journal of Drug Delivery Science and Technology, ISSN 1773-2247, Vol. 33, p. 125-135Article in journal (Refereed) Published
Abstract [en]

Trans resveratrol (RSV) is a natural molecule proved for cardioprotective effects, vasodilation, anti-inflammatory, cancer preventive and therapeutic activities devoid of any potential side effects. Recently, anti cancer potential against glioma cells were also reported with proven molecular mechanisms. However, the therapeutic application of RSV in clinical disease management is restricted because of its rapid elimination from systemic circulation and thereby low biological half life in mammals. Therefore, the main objective of this study was to improve the systemic circulation and biological half life of RSV using DSPE PEG 2000 decorated (PEGylated) liposomes. Moreover, brain distribution of RSV loaded PEGylated liposomes (RSV-PEG-Lipo) and non-PEGylated liposomes (RSV-Lipo) was also evaluated for proving their passive brain targeting ability. In vitro drug release of both liposomes was found to be sustained up to 48 h. RSV-PEG-Lipo showed higher area under the curve, plasma half life and mean residence time and lower volume of distribution and clearance than that of pristine RSV solution and RSV-Lipo. Pharmaokinetics results clearly indicated that the RSV-PEG-Lipo will be promising tool for enhancing plasma half life and prolong the systemic circulation of RSV. Brain distribution studies revealed that the liposomal formulations can be applied as an effective tool for passive brain targeting useful in the treatment of glioma.

Place, publisher, year, edition, pages
2016. Vol. 33, p. 125-135
National Category
Other Health Sciences
Research subject
Health Science
Identifiers
URN: urn:nbn:se:ltu:diva-13714DOI: 10.1016/j.jddst.2016.02.009ISI: 000378453600013Scopus ID: 2-s2.0-84964355644Local ID: cffbf203-093a-437a-85a0-a17812907102OAI: oai:DiVA.org:ltu-13714DiVA, id: diva2:986667
Note
Validerad; 2016; Nivå 2; 20160229 (andbra)Available from: 2016-09-29 Created: 2016-09-29 Last updated: 2018-07-10Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textScopus

Authority records BETA

Vuddanda, Parameswara Rao

Search in DiVA

By author/editor
Vuddanda, Parameswara Rao
By organisation
Medical Science
In the same journal
Journal of Drug Delivery Science and Technology
Other Health Sciences

Search outside of DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 145 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf